Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A | Erlotinib | 0.1 | uM | 9 | 312.50 | 96.23 | 826.00 | 835.25 | 0.9889 | 0.9929 |
| MCF 10A | 0 | uM | 9 | 312.50 | 96.23 | 999.00 | 835.25 | 1.1960 | 1.1182 | |
| MCF 10A | Erlotinib | 19.9526 | uM | 9 | 312.50 | 96.23 | 55.00 | 835.25 | 0.0658 | -0.1643 |
| MCF 10A | Lapatinib | 0.031623 | uM | 9 | 312.50 | 96.23 | 855.00 | 835.25 | 1.0236 | 1.0150 |
| MCF 10A | Lapatinib | 0.0016596 | uM | 9 | 312.50 | 96.23 | 760.00 | 835.25 | 0.9099 | 0.9403 |
| MCF 10A | 17-AAG | 0.031623 | uM | 9 | 312.50 | 96.23 | 60.00 | 835.25 | 0.0718 | -0.1406 |
| MCF 10A | 0 | uM | 9 | 312.50 | 96.23 | 615.00 | 835.25 | 0.7363 | 0.8130 | |
| MCF 10A | 0 | uM | 9 | 625.00 | 186.95 | 3284.00 | 3189.50 | 1.0296 | 1.0143 | |
| MCF 10A | Erlotinib | 0.01 | uM | 9 | 625.00 | 186.95 | 3403.00 | 3189.50 | 1.0669 | 1.0319 |
| MCF 10A | 17-AAG | 0.000302 | uM | 9 | 625.00 | 186.95 | 2882.00 | 3189.50 | 0.9036 | 0.9511 |
| MCF 10A | Erlotinib | 0.31623 | uM | 9 | 625.00 | 186.95 | 1676.00 | 3189.50 | 0.5255 | 0.7090 |
| MCF 10A | Erlotinib | 1 | uM | 9 | 625.00 | 186.95 | 367.00 | 3189.50 | 0.1151 | 0.1792 |
| MCF 10A | Lapatinib | 10 | uM | 9 | 625.00 | 186.95 | 235.00 | 3189.50 | 0.0737 | 0.0575 |
| MCF 10A | Linsitinib | 0.031623 | uM | 9 | 625.00 | 186.95 | 3297.00 | 3189.50 | 1.0337 | 1.0163 |
| MCF 10A | 17-AAG | 0.0001 | uM | 9 | 625.00 | 186.95 | 3899.00 | 3189.50 | 1.2224 | 1.1006 |
| MCF 10A | Erlotinib | 0.031623 | uM | 9 | 625.00 | 186.95 | 3570.00 | 3189.50 | 1.1193 | 1.0558 |
| MCF 10A | Lapatinib | 1 | uM | 9 | 625.00 | 186.95 | 4015.00 | 3189.50 | 1.2588 | 1.1157 |
| MCF 10A | Linsitinib | 10 | uM | 9 | 625.00 | 186.95 | 1004.00 | 3189.50 | 0.3148 | 0.5079 |
| MCF 10A | Erlotinib | 3.1623 | uM | 9 | 625.00 | 186.95 | 290.00 | 3189.50 | 0.0909 | 0.1132 |
| MCF 10A | Erlotinib | 10 | uM | 9 | 625.00 | 186.95 | 266.00 | 3189.50 | 0.0834 | 0.0900 |
| MCF 10A | Linsitinib | 0.31623 | uM | 9 | 625.00 | 186.95 | 2365.00 | 3189.50 | 0.7415 | 0.8591 |
| MCF 10A | Linsitinib | 0.0033113 | uM | 9 | 625.00 | 186.95 | 3523.00 | 3189.50 | 1.1046 | 1.0492 |
| MCF 10A | 17-AAG | 0.01 | uM | 9 | 625.00 | 186.95 | 1060.00 | 3189.50 | 0.3323 | 0.5280 |
| MCF 10A | Lapatinib | 3.1623 | uM | 9 | 625.00 | 186.95 | 1468.00 | 3189.50 | 0.4603 | 0.6546 |
| MCF 10A | 17-AAG | 0.001 | uM | 9 | 625.00 | 186.95 | 2993.00 | 3189.50 | 0.9384 | 0.9692 |